Sentara Infusion Services: Drug Recall
Recall #D-0320-2023 · 12/27/2022
Class II: Risk
Recall Details
- Recall Number
- D-0320-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Sentara Infusion Services
- Status
- Completed
- Date Initiated
- 12/27/2022
- Location
- Chesapeake, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31 bags
Reason for Recall
Lack of sterility assurance
Product Description
TPN (a) 115GM/AA, 215GM/DEX, 25GM/LIP 1150ML, (b)90GM/AA, 215GM/DEX, 25GM/LIP 1150ML, (c) TPN AA: 100GM DEX: 105GM 2700ML, (d) TPN AA: 100GM DEX: 105GM LIP: 45GM 2700ML, (e) TPN: AA100GM ; DEX185GM ; LIP50GM IN 1500ML, (f) TPN: AA 150GM ; DEX 220GM ; LIP 45GM IN 2400 ml, (g) TPN: AA 60GM ; DEX 200GM ; LIP 30GM IN 1500 ml, Rx only, use with Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Distribution Pattern
Dispensed to Patients Nationwide.
Other Recalls by Sentara Infusion Services
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
- Class II: Risk 12/27/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.